These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31022155)

  • 21. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review.
    Wolff RF; Bala MM; Westwood M; Kessels AG; Kleijnen J
    Acta Neurol Scand; 2011 May; 123(5):295-309. PubMed ID: 21039364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clarifying the use of lidoderm patch to treat pain associated with postherpetic neuralgia.
    Alvarez NA
    Reg Anesth Pain Med; 2004; 29(1):75; author reply 75. PubMed ID: 14727292
    [No Abstract]   [Full Text] [Related]  

  • 23. Transition from Injectable to Percutaneous Local Anesthetic Therapy in a Patient with Post-Herpetic Neuralgia.
    Riopelle J; Kaye AD
    Pain Physician; 2016 Feb; 19(2):E359-60. PubMed ID: 26815265
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia.
    Binder A; Rogers P; Hans G; Baron R
    Pain Manag; 2016; 6(3):229-39. PubMed ID: 26821240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients - subgroup analyses from three European clinical trials.
    Sabatowski R; Bösl I; König S; Buchheister B; Meier T; Baron R
    Curr Med Res Opin; 2017 Mar; 33(3):595-603. PubMed ID: 28035844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom.
    Dakin H; Nuijten M; Liedgens H; Nautrup BP
    Clin Ther; 2007 Jul; 29(7):1491-507. PubMed ID: 17825701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical inquiries: What measures relieve postherpetic neuralgia?
    Garroway N; Chhabra S; Landis S; Skolnik DC
    J Fam Pract; 2009 Jul; 58(7):384d-f. PubMed ID: 19607770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capsaicin patch (Qutenza) for postherpetic neuralgia.
    Med Lett Drugs Ther; 2011 May; 53(1365):42-3. PubMed ID: 21617594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
    Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
    Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5% lidocaine medicated plasters vs. sympathetic nerve blocks as a part of multimodal treatment strategy for the management of postherpetic neuralgia: a retrospective, consecutive, case-series study.
    Malec-Milewska M; Horosz B; Sękowska A; Kolęda I; Kucia H; Kosson D
    Neurol Neurochir Pol; 2015; 49(1):24-8. PubMed ID: 25666769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local Injection of Methylcobalamin Combined with Lidocaine for Acute Herpetic Neuralgia.
    Xǔ G; Xu S; Tang WZ; Xú G; Cheng C; Xu J
    Pain Med; 2016 Mar; 17(3):572-581. PubMed ID: 26814241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonopioid drugs for pain.
    Med Lett Drugs Ther; 2018 Feb; 60(1540):25-32. PubMed ID: 29422479
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention and treatment of postherpetic neuralgia.
    Baron R; Wasner G
    Lancet; 2006 Jan; 367(9506):186-8. PubMed ID: 16427472
    [No Abstract]   [Full Text] [Related]  

  • 34. Capsaicin 8% topical patch (Qutenza)--a review of the evidence.
    Jones VM; Moore KA; Peterson DM
    J Pain Palliat Care Pharmacother; 2011; 25(1):32-41. PubMed ID: 21426216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Postherpetic Neuralgia with 5% Topical Lidocaine Plaster – Experience from a Small County Hospital: Case Report.
    Kontić M; Vičić-Hudorović V; Hudorović N
    Acta Clin Croat; 2016 Dec; 55(4):655-658. PubMed ID: 29117658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
    Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
    Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza).
    Katz NP; Mou J; Paillard FC; Turnbull B; Trudeau J; Stoker M
    Clin J Pain; 2015 Oct; 31(10):859-66. PubMed ID: 25503598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lidocaine Transdermal Patch: Pharmacokinetic Modeling and In Vitro-In Vivo Correlation (IVIVC).
    Kondamudi PK; Tirumalasetty PP; Malayandi R; Mutalik S; Pillai R
    AAPS PharmSciTech; 2016 Jun; 17(3):588-96. PubMed ID: 26283198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
    Irving GA; Backonja MM; Dunteman E; Blonsky ER; Vanhove GF; Lu SP; Tobias J;
    Pain Med; 2011 Jan; 12(1):99-109. PubMed ID: 21087403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentrations of lidocaine in dogs following lidocaine patch application over an incision compared to intact skin.
    Joudrey SD; Robinson DA; Kearney MT; Papich MG; da Cunha AF
    J Vet Pharmacol Ther; 2015 Dec; 38(6):575-80. PubMed ID: 25846945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.